Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ferrero

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Minerva Chirurgica|January 31, 1970
[Usefulness of endoarterial therapy with radioactive microspheres in locally inoperable cancer of the breast]L Caldarola, F Badellino, P Calderini, et al.
Human Molecular Genetics|July 1, 1993
The genes for X-linked ocular albinism (OA1) and microphthalmia with linear skin defects (MLS): cloning and characterization of the critical regionsM C Wapenaar, M T Bassi, L Schaefer, et al.
Journal of Inherited Metabolic Disease|January 1, 1990
Haplotype distribution and molecular defects of PKU in ItalyI Dianzani, C Camaschella, G Saglio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1995
Interferon alpha treatment of relapsing-remitting multiple sclerosis: long-term study of the correlations between clinical and magnetic resonance imaging results and effects on the immune functionL Durelli, M R Bongioanni, R Cavallo, et al.
Neurology|July 1, 1996
Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: disease activity resumes after stopping treatmentL Durelli, M R Bongioanni, B Ferrero, et al.
Journal of Inherited Metabolic Disease|January 1, 1996
Monitoring treatment in tetrahydrobiopterin deficiency by serum prolactinM Spada, S Ferraris, G B Ferrero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with NabP Barbero, M Bergui, E Versino, et al.
Neurology|March 1, 1994
Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosisL Durelli, M R Bongioanni, R Cavallo, et al.
Clinical Laboratory|May 20, 2026
GDF15 as a Marker of Ineffective Erythropoiesis and Erythroid Expansion in Thalassemia: a Clinical PerspectiveAndrea Piolatto, Nicolò Tesio, Martina Teti, et al.
Journal of Medical Genetics|October 1, 1996
X linked spondyloepiphyseal dysplasia: a clinical, radiological, and molecular study of a large kindredJ J MacKenzie, J Fitzpatrick, P Babyn, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Minerva Chirurgica|January 31, 1970
[Usefulness of endoarterial therapy with radioactive microspheres in locally inoperable cancer of the breast]L Caldarola, F Badellino, P Calderini, et al.
Human Molecular Genetics|July 1, 1993
The genes for X-linked ocular albinism (OA1) and microphthalmia with linear skin defects (MLS): cloning and characterization of the critical regionsM C Wapenaar, M T Bassi, L Schaefer, et al.
Journal of Inherited Metabolic Disease|January 1, 1990
Haplotype distribution and molecular defects of PKU in ItalyI Dianzani, C Camaschella, G Saglio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1995
Interferon alpha treatment of relapsing-remitting multiple sclerosis: long-term study of the correlations between clinical and magnetic resonance imaging results and effects on the immune functionL Durelli, M R Bongioanni, R Cavallo, et al.
Neurology|July 1, 1996
Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: disease activity resumes after stopping treatmentL Durelli, M R Bongioanni, B Ferrero, et al.
Journal of Inherited Metabolic Disease|January 1, 1996
Monitoring treatment in tetrahydrobiopterin deficiency by serum prolactinM Spada, S Ferraris, G B Ferrero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with NabP Barbero, M Bergui, E Versino, et al.
Neurology|March 1, 1994
Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosisL Durelli, M R Bongioanni, R Cavallo, et al.
Clinical Laboratory|May 20, 2026
GDF15 as a Marker of Ineffective Erythropoiesis and Erythroid Expansion in Thalassemia: a Clinical PerspectiveAndrea Piolatto, Nicolò Tesio, Martina Teti, et al.
Journal of Medical Genetics|October 1, 1996
X linked spondyloepiphyseal dysplasia: a clinical, radiological, and molecular study of a large kindredJ J MacKenzie, J Fitzpatrick, P Babyn, et al.
Pageof 10